First identification of metallo-beta-lactamase-producing Pseudomonas aeruginosa in the Czech Republic

J Hrabák1, M Fridrichová, M Stolbová

  • 1Department of Microbiology, Faculty of Medicine and University Hospital in Plzen, Charles University in Prague, Plzen, Czech Republic.

Insights

Metallo-beta-lactamase (MBL) producing Pseudomonas aeruginosa strains were absent in the Czech Republic for three years. Two IMP-7 MBL-producing strains were detected in 2008, highlighting the emergence of antibiotic resistance.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Pseudomonas aeruginosa is a significant opportunistic pathogen.
  • Invasive isolates are monitored in the Czech Republic via the European Antibiotic Resistance Surveillance System (EARSS) since 2005.
  • Surveillance covers 48 laboratories and approximately 81% of the population, analyzing blood and cerebrospinal fluid isolates.

Observation:

  • Over a three-year period, 1,259 invasive Pseudomonas aeruginosa isolates were tested.
  • No metallo-beta-lactamase (MBL) producing strains were detected until mid-2008.
  • Two MBL-producing strains were identified in isolates from a single regional hospital.

Findings:

  • The detected metallo-beta-lactamase was identified as IMP-7.
  • IMP-7 is a carbapenemase previously reported in Canada, Japan, Malaysia, and Slovakia.
  • This marks the first detection of MBL-producing Pseudomonas aeruginosa in invasive isolates in the Czech Republic.

Implications:

  • The emergence of IMP-7 in the Czech Republic necessitates enhanced surveillance for MBL-producing bacteria.
  • This finding underscores the dynamic nature of antimicrobial resistance spread across geographical regions.
  • Understanding the epidemiology of IMP-7 is crucial for guiding infection control strategies and antibiotic stewardship.

Related Concept Videos

Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...